Conexeu Sciences, Inc. (CNXU)
3.32
-0.45
(-11.94%)
USD |
NASDAQ |
Oct 13, 16:00
3.32
0.00 (0.00%)
After-Hours: 20:00
Conexeu Sciences Cash from Investing (Quarterly) : -0.0414M for July 31, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2026 | -0.0414M |
| April 30, 2026 | -0.0301M |
| Date | Value |
|---|---|
| January 31, 2026 | |
| April 30, 2025 | -0.0048M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| AbbVie, Inc. | -1.197B |
| Vericel Corp. | -2.82M |
| ACADIA Pharmaceuticals, Inc. | -8.529M |
| Alnylam Pharmaceuticals, Inc. | -363.46M |
| Anika Therapeutics, Inc. | -1.28M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -6.759M |
| Cash from Financing (Quarterly) | 1.705M |
| Free Cash Flow Per Share (Quarterly) | -0.2482 |
| Free Cash Flow to Equity (Quarterly) | -6.873M |
| Free Cash Flow to Firm (Quarterly) | -6.797M |